Glaxo Wins Appeal Against Pfizer Inhaler Dose Patent
Glaxo Group has persuaded European officials to revoke Pfizer's patent covering a dose-counting device for inhalers, after an appeals board found the design was not new because earlier devices already included...To view the full article, register now.
Already a subscriber? Click here to view full article